Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000834365-25-000007
Filing Date
2025-07-08
Accepted
2025-07-08 16:58:06
Documents
20
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 DEF 14A blfs-20250708.htm   iXBRL DEF 14A 826770
3 GRAPHIC blfs-20250708_g1.jpg GRAPHIC 6233
4 GRAPHIC blfs-20250708_g2.jpg GRAPHIC 109215
5 GRAPHIC blfs-20250708_g3.jpg GRAPHIC 130123
6 GRAPHIC blfs-20250708_g4.jpg GRAPHIC 114379
7 GRAPHIC blfs-20250708_g5.jpg GRAPHIC 193736
8 GRAPHIC blfs-20250708_g6.jpg GRAPHIC 234937
9 GRAPHIC blfs-20250708_g7.jpg GRAPHIC 396492
  Complete submission text file 0000834365-25-000007.txt   4482530

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT blfs-20250708.xsd EX-101.SCH 940
22 EXTRACTED XBRL INSTANCE DOCUMENT blfs-20250708_htm.xml XML 109609
Mailing Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021
Business Address 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 4254011400
BIOLIFE SOLUTIONS INC (Filer) CIK: 0000834365 (see all company filings)

EIN.: 943076866 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36362 | Film No.: 251111546
SIC: 3845 Electromedical & Electrotherapeutic Apparatus
(CF Office: 08 Industrial Applications and Services)